FOAMIX PHARMACEUTICALS LTD's ticker is FOMX and the CUSIP is M46135105. A total of 60 filers reported holding FOAMIX PHARMACEUTICALS LTD in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $33,000 | -92.7% | 10,898 | -94.2% | 0.00% | – |
Q2 2019 | $450,000 | +800.0% | 189,511 | +1295.4% | 0.00% | – |
Q1 2019 | $50,000 | +47.1% | 13,581 | +131.1% | 0.00% | – |
Q3 2018 | $34,000 | -87.8% | 5,877 | -89.5% | 0.00% | – |
Q2 2018 | $279,000 | +416.7% | 55,903 | +429.1% | 0.00% | – |
Q1 2018 | $54,000 | +3.8% | 10,565 | +21.4% | 0.00% | – |
Q4 2017 | $52,000 | -44.7% | 8,706 | -49.2% | 0.00% | – |
Q3 2017 | $94,000 | -81.3% | 17,142 | -84.2% | 0.00% | – |
Q2 2017 | $502,000 | +112.7% | 108,222 | +125.9% | 0.00% | – |
Q1 2017 | $236,000 | +3.1% | 47,898 | +132.1% | 0.00% | – |
Q4 2016 | $229,000 | -9.1% | 20,637 | -24.3% | 0.00% | – |
Q3 2016 | $252,000 | -55.7% | 27,269 | -69.6% | 0.00% | – |
Q2 2016 | $569,000 | +62.1% | 89,665 | +65.8% | 0.00% | – |
Q1 2016 | $351,000 | -25.3% | 54,079 | -7.0% | 0.00% | – |
Q4 2015 | $470,000 | -10.3% | 58,169 | -19.0% | 0.00% | – |
Q3 2015 | $524,000 | -1.5% | 71,806 | +38.1% | 0.00% | – |
Q2 2015 | $532,000 | +120.7% | 52,009 | +50.8% | 0.00% | – |
Q4 2014 | $241,000 | +36.2% | 34,499 | +5.8% | 0.00% | – |
Q3 2014 | $177,000 | – | 32,609 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DSC Advisors, L.P. | 1,667,377 | $15,440,000 | 9.38% |
GREAT POINT PARTNERS LLC | 2,769,425 | $25,645,000 | 6.54% |
Opaleye Management Inc. | 630,000 | $5,834,000 | 3.05% |
Vivo Capital, LLC | 855,000 | $7,917,000 | 2.47% |
DAFNA Capital Management LLC | 278,067 | $2,575,000 | 1.79% |
RA Capital Management | 1,820,138 | $16,854,000 | 1.74% |
SENZAR ASSET MANAGEMENT, LLC | 523,397 | $4,846,656,000 | 1.25% |
Perceptive Advisors | 1,373,284 | $12,717,000 | 0.82% |
Monashee Investment Management LLC | 225,000 | $2,084,000 | 0.73% |
NEXTHERA CAPITAL LP | 125,000 | $1,158,000 | 0.71% |